About Sai Life Sciences
Sai Life Sciences is a company based in Hyderabad (India) founded in 1999.. Sai Life Sciences has raised $112.18 million across 10 funding rounds from investors including Tata Capital, TPG and HBM Healthcare Investments. The company has 3,400 employees as of March 31, 2024. Sai Life Sciences operates in a competitive market with competitors including Acies Bio, Liverpool ChiroChem, SpiroChem, IRBM and Personal Chemistry, among others.
- Headquarter Hyderabad, India
- Employees 3400 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sai Life Sciences Ltd.
-
Annual Revenue
$198.13 M (USD)15.46as on Mar 31, 2024
-
Net Profit
$19.86 M (USD)105.45as on Mar 31, 2024
-
EBITDA
$48.36 M (USD)38.96as on Mar 31, 2024
-
Total Equity Funding
$112.18 M (USD)
in 10 rounds
-
Latest Funding Round
$1.14 M (USD), Angel Round
Jul 03, 2024
-
Investors
Tata Capital
& 14 more
-
Employee Count
3400
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sai Life Sciences
Sai Life Sciences is a publicly listed company on the NSE with ticker symbol SAILIFE in India, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Leadership Team
25 people
Human Resources and Administration
12 people
Sales and Marketing
10 people
Software Development Team
7 people
Assistant Team
6 people
Finance and Accounting
4 people
Deputy Team
3 people
Manager Team
3 people
Unlock access to complete
Funding Insights of Sai Life Sciences
Sai Life Sciences has successfully raised a total of $112.18M across 10 strategic funding rounds. The most recent funding activity was a Angel Round round of $1.14 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Angel Round — $1.1M
-
First Round
First Round
(16 Aug 2006)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Angel Round - Sai Life Sciences | Valuation | Fred Cohen |
|
| Jul, 2022 | Amount | Angel Round - Sai Life Sciences | Valuation | Jagdish V Dore |
|
| Jul, 2021 | Amount | Angel Round - Sai Life Sciences | Valuation | Jagdish V Dore |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sai Life Sciences
Sai Life Sciences has secured backing from 15 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Tata Capital, TPG and HBM Healthcare Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fund of funds focused on pre-seed and seed-stage companies
|
Founded Year | Domain | Location | |
|
Late-stage life sciences investments are managed via VC and PE.
|
Founded Year | Domain | Location | |
|
Life sciences focused VC firm funding companies in the US and Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sai Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sai Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sai Life Sciences Comparisons
Competitors of Sai Life Sciences
Sai Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Acies Bio, Liverpool ChiroChem, SpiroChem, IRBM and Personal Chemistry, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| domain | founded_year | HQ Location |
Small organic molecules are supplied for biotech and pharmaceutical R&D.
|
|
| domain | founded_year | HQ Location |
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
|
|
| domain | founded_year | HQ Location |
Integrated drug discovery and preclinical development services are provided.
|
|
| domain | founded_year | HQ Location |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sai Life Sciences
Frequently Asked Questions about Sai Life Sciences
When was Sai Life Sciences founded?
Sai Life Sciences was founded in 1999 and raised its 1st funding round 7 years after it was founded.
Where is Sai Life Sciences located?
Sai Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Who is the current CEO of Sai Life Sciences?
Krishna Kanumuri is the current CEO of Sai Life Sciences.
Is Sai Life Sciences a funded company?
Sai Life Sciences is a funded company, having raised a total of $112.18M across 10 funding rounds to date. The company's 1st funding round was a Angel Round of $106.92K, raised on Aug 16, 2006.
How many employees does Sai Life Sciences have?
As of Mar 31, 2024, the latest employee count at Sai Life Sciences is 3,400.
What is the annual revenue of Sai Life Sciences?
Annual revenue of Sai Life Sciences is $198.13M as on Mar 31, 2024.
What does Sai Life Sciences do?
Sai Life Sciences was founded in 1999 in Hyderabad, India, and operates in the pharmaceutical sector. Services in drug discovery, development, and manufacturing of complex small molecules are offered, including synthetic and medicinal chemistry, pre-clinical toxicology, and DMPK studies. CMC operations cover pre-formulation, analytical development, stability studies, lyophilization, liposome processes, and formulation development.
Who are the top competitors of Sai Life Sciences?
Sai Life Sciences's top competitors include Acies Bio, Liverpool ChiroChem and IRBM.
Is Sai Life Sciences publicly traded?
Yes, Sai Life Sciences is publicly traded on NSE under the ticker symbol SAILIFE.
Who are Sai Life Sciences's investors?
Sai Life Sciences has 15 investors. Key investors include Tata Capital, TPG, HBM Healthcare Investments, Fred Cohen, and Jagdish V Dore.
What is Sai Life Sciences's ticker symbol?
The ticker symbol of Sai Life Sciences is SAILIFE on NSE.
What is Sai Life Sciences's valuation?
The valuation of Sai Life Sciences is $563.73M as of Jul 2024.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.